Results 171 to 180 of about 10,275 (197)
Some of the next articles are maybe not open access.

Theranostic implications of Nectin-4 oncoprotein in gynecologic cancers: A review

Pathology - Research and Practice
Gynecologic cancers, in order of prevalence, include uterine, ovarian, cervical, vaginal, and vulvar cancers. In 2024, there will be more than 116,000 new cases of gynecologic cancers and 33,800 disease-related deaths. Therefore, a concerted effort has been made to better understand the underlying pathophysiological processes and identify novel ...
Olivia Hooks   +4 more
openaire   +2 more sources

Abstract 6582: Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors

Cancer Research
Abstract Background: Nectin-4 is a cell membrane adhesion protein overexpressed in several solid tumors, including urothelial, breast, lung, ovarian, and pancreatic cancers, with limited expression in normal tissues, making it an ideal target for antibody-drug conjugates (ADC).
Romain Remark   +23 more
openaire   +1 more source

Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy

European Journal of Pharmacology, 2021
Subhajit Chatterjee   +2 more
exaly  

Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion

Nature Genetics, 2022
Julien Ablain   +2 more
exaly  

Nectin-2 in general and in the brain

Molecular and Cellular Biochemistry, 2021
Kiyohito Mizutani   +2 more
exaly  

Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma

Expert Opinion on Biological Therapy, 2021
Jeffrey L Wong, Jonathan E Rosenberg
exaly  

Home - About - Disclaimer - Privacy